Salbutamol - oral

Generic name
Salbutamol - oral
Brand name
ATC Code
R03CC02
Compare …

Salbutamol - oral

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No pediatric pharmacokinetic data available 

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Obstructive airway diseases
  • Oral
    • 2 months up to 2 years
      [1]
      • Initial dose: (Salbutamol) 0.15 mg/kg/day in 3 doses. Max single dose: 2 mg/dose.
      • Maintenance dose: increase if needed based on efficay and tolerability to  0.3 - 0.6 mg/kg/day in 3 doses. Max: 6 mg/day. Max single dose: 2 mg/dose.
    • 2 years up to 14 years
      [1]
      • (Salbutamol) 4 - 8 mg/day in 2 - 4 doses. Max single dose: 2 mg/dose.
    • ≥ 14 years
      [1]
      • (Salbutamol) 12 - 16 mg/day in 3 - 4 doses. Max single dose: 4 mg/dose.
    • 2 months up to 2 years
      • Initial dose: (Salbutamol) 0.15 mg/kg/day in 3 doses. Max single dose: 2 mg/dose.
      • Maintenance dose: increase if needed based on efficay and tolerability to  0.3 - 0.6 mg/kg/day in 3 doses. Max: 6 mg/day. Max single dose: 2 mg/dose.
    • 2 years up to 14 years
      • (Salbutamol) 4 - 8 mg/day in 2 - 4 doses. Max single dose: 2 mg/dose.
    • ≥ 14 years
      • (Salbutamol) 12 - 16 mg/day in 3 - 4 doses. Max single dose: 4 mg/dose.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ADRENERGICS FOR SYSTEMIC USE

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Selective beta-2-adrenoreceptor agonists
R03CC14

References

  1. Infectopharm, SmPC SalbuBronch Elixier (6120.7015.00.00), May 2020
  2. INFECTOPHARM Arzneimittel und Consilium GmbH, SmPC SALBUBRONCH® Elixier (6120715.00.00), 01/2024

Changes

Therapeutic Drug Monitoring


Overdose